Emergent BioSolutions (EBS) Receivables - Other (2017 - 2026)
Emergent BioSolutions (EBS) posted quarterly Receivables - Other of $18.3 million for Q1 2026, down 40.78% year-over-year from $30.9 million in Q1 2025, and up 0.55% quarter-over-quarter from $18.2 million in Q4 2025.
Emergent BioSolutions (EBS) Receivables - Other (2017 - 2026) Analysis & Trends
Emergent BioSolutions' Receivables - Other history runs 10 years deep, the most recent figure standing at $18.3 million for Q1 2026.
- In Q1 2026, Receivables - Other fell 40.78% year-over-year to $18.3 million; the TTM figure through Mar 2026 stood at $18.3 million (down 40.78% YoY), while the FY2025 annual figure was $18.2 million, down 7.14% from the prior year.
- Receivables - Other for Q1 2026 stood at $18.3 million, up from $18.2 million in the prior quarter.
- The five-year high for Receivables - Other was $82.5 million in Q2 2024, with the low at $18.2 million in Q4 2025.
- The 5-year median for Receivables - Other is $49.8 million (2023), against an average of $43.4 million.
- The sharpest annual moves came in 2024 and 2025: Receivables - Other surged 59.27% in 2024, then slumped 72.24% in 2025.
- Emergent BioSolutions' Receivables - Other stood at $57.2 million in 2022, then fell by 10.14% to $51.4 million in 2023, then slumped by 61.87% to $19.6 million in 2024, then retreated by 7.14% to $18.2 million in 2025, then rose by 0.55% to $18.3 million in 2026.
- Business Quant data shows EBS's Receivables - Other at $18.3 million in Q1 2026, $18.2 million in Q4 2025, and $19.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.20 Mn |
| Jun 30, 2026 | 21.20 Mn |
| Mar 31, 2026 | 18.30 Mn |
| Mar 31, 2026 | 18.30 Mn |
| Dec 31, 2025 | 18.20 Mn |
| Dec 31, 2025 | 18.20 Mn |
| Sep 30, 2025 | 19.30 Mn |
| Sep 30, 2025 | 19.30 Mn |
| Jun 30, 2025 | 22.90 Mn |
| Jun 30, 2025 | 22.90 Mn |
| Mar 31, 2025 | 30.90 Mn |
| Mar 31, 2025 | 30.90 Mn |
| Dec 31, 2024 | 19.60 Mn |
| Dec 31, 2024 | 19.60 Mn |
| Sep 30, 2024 | 19.20 Mn |
| Sep 30, 2024 | 19.20 Mn |
| Jun 30, 2024 | 82.50 Mn |
| Jun 30, 2024 | 82.50 Mn |
| Mar 31, 2024 | 41.60 Mn |
| Mar 31, 2024 | 41.60 Mn |